본문바로가기
Wellmarker Bio, a predictive biomarker based anti-cancer drug development company has raised $18million in Series B funding round in 8th of July. 

LInk: http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019070814443711496

返回